At HBI 2026, a panel discussed the trends and innovations driving growth in this industry, focusing on the strategies that help these businesses scale and create value for measurable returns.
Amulet Capital Partners, a US middle-market healthcare-focused private equity firm, has acquired a majority stake in UK-based fertility provider TFP Fertility Group from American investment firm Benefit Street Partners.
Spire Healthcare, the UK’s largest private hospital group, has received a non-binding takeover proposal from British investment firm Toscafund Asset Management, its second-largest shareholder, at 250 pence per share in cash. The offer values the company at around £1.35 billion.
Italian pharmaceutical company Angelini Pharma is acquiring US-based commercial-stage biopharmaceutical company Catalyst Pharmaceuticals for ~$4.1 billion in terms of equity value.
California-based private equity and credit firm Ares Management is joining as a new financing partner for Linimed Gruppe, Germany’s largest provider of out-of-hospital intensive care. It will invest alongside existing lenders global asset management firm BlackRock and Hamburg-based investment firm Berenberg, while London-based private equity firm GHO Capital remains the company’s majority shareholder.
Swiss-based multinational healthcare company Roche has agreed to acquire PathAI, a US-based AI-powered digital pathology firm, for ~$1.05 billion. Roche will pay $750 million upfront and additional milestone payments of up to $300 million.
HBI spoke with Skingevity co‑founders Andrea Agnolio (former Principal at The Boston Consulting Group) and Enrico Ghio (former Executive Director at Goldman Sachs) about their strategy, why now is the right time to consolidate the UK aesthetics market, and the key trends shaping the sector.
Pan-European French nursing home group DomusVi has announced a major refinancing and capital raise, restructuring €2 billion in debt to strengthen its balance sheet and extend debt maturities.
Hospitals, facing increased pressure on their budgets, are turning to procurement as a strategic lever for cost control and resilience. At HBI 2026, as part of the Procurement Summit, panellists explored how hospitals can drive value creation through smarter procurement.
Speakers at HBI’s 2026 conference working on various projects attempting to harness the latent potential of genomic data shared some insights they’d gained from this at a session entitled ‘Unleashing prevention: Models deploying genomics at scale’.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
